JOHNSON & JOHNSON (JNJ) Liabilities, Current USD 2009 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.
Summary
Johnson & Johnson quarterly Liabilities, Current history and growth rate from 2009 to 2024.
  • Johnson & Johnson Liabilities, Current for the quarter ending March 31, 2024 was $48.7B, a 19.3% decline year-over-year.
Liabilities, Current, Quarterly Data (USD)
Period Value YoY Chg Change % Date Report Filed
Q1 2024 $48.7B -$11.6B -19.3% Mar 31, 2024 10-Q 2024-05-01
Q4 2023 $46.3B -$9.52B -17.1% Dec 31, 2023 10-Q 2024-05-01
Q3 2023 $44.4B -$1.17B -2.58% Oct 1, 2023 10-Q 2023-10-27
Q2 2023 $54.2B +$9.35B +20.9% Jul 2, 2023 10-Q 2023-07-31
Q1 2023 $60.4B +$17B +39.1% Apr 2, 2023 10-Q 2023-04-28
Q4 2022 $55.8B +$10.6B +23.4% Jan 1, 2023 10-K 2024-02-16
Q3 2022 $45.5B +$982M +2.2% Oct 2, 2022 10-Q 2022-10-27
Q2 2022 $44.8B +$6.1B +15.8% Jul 3, 2022 10-Q 2022-07-29
Q1 2022 $43.4B +$2.46B +6.01% Apr 3, 2022 10-Q 2022-04-29
Q4 2021 $45.2B +$2.73B +6.43% Jan 2, 2022 10-K 2023-02-16
Q3 2021 $44.6B +$5.71B +14.7% Oct 3, 2021 10-Q 2021-10-29
Q2 2021 $38.7B +$1.95B +5.3% Jul 4, 2021 10-Q 2021-07-29
Q1 2021 $40.9B +$7.24B +21.5% Apr 4, 2021 10-Q 2021-04-30
Q4 2020 $42.5B +$6.53B +18.2% Jan 3, 2021 10-K 2022-02-17
Q3 2020 $38.8B +$3.69B +10.5% Sep 27, 2020 10-Q 2020-10-23
Q2 2020 $36.8B +$5.42B +17.3% Jun 28, 2020 10-Q 2020-07-24
Q1 2020 $33.7B +$4.58B +15.7% Mar 29, 2020 10-Q 2020-04-29
Q4 2019 $36B +$4.73B +15.2% Dec 29, 2019 10-K 2021-02-22
Q3 2019 $35.2B +$7.73B +28.2% Sep 29, 2019 10-Q 2019-10-28
Q2 2019 $31.4B +$3.87B +14.1% Jun 30, 2019 10-Q 2019-07-29
Q1 2019 $29.1B +$2.03B +7.5% Mar 31, 2019 10-Q 2019-05-01
Q4 2018 $31.2B +$693M +2.27% Dec 30, 2018 10-K 2020-02-18
Q3 2018 $27.4B -$4.37B -13.7% Sep 30, 2018 10-Q 2018-10-31
Q2 2018 $27.5B -$1.38B -4.79% Jul 1, 2018 10-Q 2018-08-02
Q1 2018 $27.1B +$1.96B +7.81% Apr 1, 2018 10-Q 2018-05-01
Q4 2017 $30.5B +$4.25B +16.2% Dec 31, 2017 10-K 2019-02-20
Q3 2017 $31.8B +$8.58B +36.9% Oct 1, 2017 10-Q 2017-11-02
Q2 2017 $28.9B +$7.34B +34.1% Jul 2, 2017 10-Q 2017-08-03
Q1 2017 $25.1B +$2.99B +13.5% Apr 2, 2017 10-Q 2017-05-08
Q4 2016 $26.3B -$1.46B -5.26% Jan 1, 2017 10-K 2018-02-21
Q3 2016 $23.2B -$2.03B -8.04% Oct 2, 2016 10-Q 2016-11-04
Q2 2016 $21.5B -$2.98B -12.1% Jul 3, 2016 10-Q 2016-08-04
Q1 2016 $22.1B -$1.7B -7.14% Apr 3, 2016 10-Q 2016-05-10
Q4 2015 $27.7B +$2.72B +10.9% Jan 3, 2016 10-K 2017-02-27
Q3 2015 $25.3B +$2.28B +9.91% Sep 27, 2015 10-Q 2015-10-30
Q2 2015 $24.5B +$153M +0.63% Jun 28, 2015 10-Q 2015-07-31
Q1 2015 $23.8B -$4M -0.02% Mar 29, 2015 10-Q 2015-05-01
Q4 2014 $25B -$644M -2.51% Dec 28, 2014 10-K 2016-02-24
Q3 2014 $23B -$2.85B -11% Sep 28, 2014 10-Q 2014-10-30
Q2 2014 $24.4B +$592M +2.49% Jun 29, 2014 10-Q 2014-08-01
Q1 2014 $23.8B +$1.32B +5.84% Mar 30, 2014 10-Q 2014-05-02
Q4 2013 $25.7B +$1.41B +5.82% Dec 29, 2013 10-K 2015-02-24
Q3 2013 $25.8B +$1.9B +7.94% Sep 29, 2013 10-Q 2013-11-04
Q2 2013 $23.8B -$81M -0.34% Jun 30, 2013 10-Q 2013-08-01
Q1 2013 $22.5B +$1.33B +6.26% Mar 31, 2013 10-Q 2013-05-03
Q4 2012 $24.3B +$1.45B +6.36% Dec 30, 2012 10-K 2014-02-21
Q3 2012 $23.9B +$2.25B +10.4% Sep 30, 2012 10-Q 2012-11-09
Q2 2012 $23.8B +$2.86B +13.6% Jul 1, 2012 10-Q 2012-08-02
Q1 2012 $21.2B -$2.81B -11.7% Apr 1, 2012 10-Q 2012-05-07
Q4 2011 $22.8B -$261M -1.13% Jan 1, 2012 10-K 2013-02-22
Q3 2011 $21.7B +$4.27B +24.5% Oct 2, 2011 10-Q 2011-11-08
Q2 2011 $21B +$3.82B +22.3% Jul 3, 2011 10-Q 2011-08-09
Q1 2011 $24B +$5.51B +29.8% Apr 3, 2011 10-Q 2011-05-10
Q4 2010 $23.1B +$1.34B +6.17% Jan 2, 2011 10-K 2012-02-23
Q3 2010 $17.4B Oct 3, 2010 10-Q 2010-11-10
Q2 2010 $17.2B Jul 4, 2010 10-Q 2010-08-11
Q1 2010 $18.5B Apr 4, 2010 10-Q 2010-05-10
Q4 2009 $21.7B Jan 3, 2010 10-K 2011-02-25
* An asterisk sign (*) next to the value indicates that the value is likely invalid.